Table 1 The correlations of MIR4435-2HG with clinicopathological features of ovarian cancer *P < 0.05
From: LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
Factor | No. | LNCRNA MIR4435-2HG n (%) | P value | |
|---|---|---|---|---|
Low expression (n = 21) | High expression (n = 21) | |||
Age | 0.682 | |||
≤ 55 | 22 | 10 (45.5) | 12 (54.5) | |
> 55 | 20 | 11 (55.0) | 9 (45.0) | |
Tumor size | 0.031* | |||
≤ 5 | 24 | 14 (58.3) | 10 (41.7) | |
> 5 | 18 | 7 (36.8) | 11 (63.2) | |
FIGO stage | 0.026* | |||
I + II | 16 | 10 (62.5) | 6 (37.5) | |
III + IV | 26 | 11 (42.3) | 15 (57.3) | |
Histological type | 0.450 | |||
Serous | 28 | 13 (46.4) | 15 (53.6) | |
Nonserous | 14 | 8 (47.9) | 6 (52.1) | |
Lymph node metastasis | 0.012* | |||
No | 23 | 15 (65.2) | 8 (34.8) | |
Yes | 19 | 6 (31.6) | 13 (68.4) | |